You can get access to information on Huons and its development of new products

• 36
  PanGen posts Q1 sales of 3.4 billion won and operating profit of 700 million won 휴온스 · 2025.05.14
• 35
  Huons sees limited impact on its exports from Trump’s executive order aiming at lowering drug prices 휴온스 · 2025.05.14
• 34
  Huons Announces Two US FDA Approvals for Multiple-dose Lidocaine Anesthetics 휴온스 · 2025.05.07
• 33
  Huons records Q1 sales of 145.8 billion KRW, operating profit of 12.8 billion KRW 휴온스 · 2025.05.02
• 32
  Huons Group to Launch Specialized Health Functional Food Company ‘Huons N’ 휴온스 · 2025.05.02
• 31
  Huons acquires Authorized Economic Operator (AEO) status from Korea Customs Service 휴온스 · 2025.04.11
• 30
  Huons Group's three listed companies hold general shareholders' meetings… “All agenda items were approved” 휴온스 · 2025.03.26
• 29
  PanGen contracts with Huonslab for biopharmaceutical process characterization study 휴온스 · 2025.03.05
• 28
  Huons Celebrates 60th Anniversary with Website Redesign 휴온스 · 2025.03.04
• 27
  Huons Foodience Receives Individually Approved health Functional Food Ingredient Approval for Dendropanax Morbifera Extract 운영자 · 2025.01.06
• 26
  Huons-Humedix Named 'Best Company for Work-Life Balance' 운영자 · 2024.12.10
• 25
  Huons Lidocaine Injection Listed as a “Next Generation World- Class Product” 운영자 · 2024.11.21
• 24
  Huons Record Revenue of KRW 146.9 billion in 3Q 운영자 · 2024.11.11
• 23
  Huons Accelerates Biopharmaceutical Development with Human-Derived Hyaluronidase 운영자 · 2024.11.08
• 22
  Huons Achieves 'A' in 2024 ESG Comprehensive Assessment 운영자 · 2024.10.30
• 21
  Huons, U.S. Patent Registered for 'Quisqualis Extract' for Prostate Health Improvement 운영자 · 2023.09.06

All Title Content Writer